These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 6277659

  • 1. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T, Negishi K, Suda M, Sawa A, Fujino M, Wakimasu M.
    Eur J Pharmacol; 1982 Jan 22; 77(2-3):137-41. PubMed ID: 6277659
    [Abstract] [Full Text] [Related]

  • 2. The choice of opioid receptor subtype in isolated preparations by dynorphins.
    Oka T, Aoki K, Kajiwara M.
    Life Sci; 1983 Jan 22; 33 Suppl 1():311-4. PubMed ID: 6141492
    [Abstract] [Full Text] [Related]

  • 3. The choice of opiate receptor subtype by neo-endorphins.
    Oka T, Negishi K, Kajiwara M, Watanabe Y, Ishizuka Y, Matsumiya T.
    Eur J Pharmacol; 1982 Apr 23; 79(3-4):301-5. PubMed ID: 6284522
    [Abstract] [Full Text] [Related]

  • 4. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
    Yoshimura K, Huidobro-Toro JP, Lee NM, Löh HH, Way EL.
    J Pharmacol Exp Ther; 1982 Jul 23; 222(1):71-9. PubMed ID: 6123594
    [No Abstract] [Full Text] [Related]

  • 5. Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations.
    Kajiwara M, Aoki K, Ishii K, Numata H, Matsumiya T, Oka T.
    Jpn J Pharmacol; 1986 Jan 23; 40(1):95-101. PubMed ID: 3007830
    [Abstract] [Full Text] [Related]

  • 6. Dynorphin-(1-13) restores the potency of morphine on the tolerant guinea pig ileum.
    Rezvani A, Way EL.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):475-9. PubMed ID: 6149134
    [Abstract] [Full Text] [Related]

  • 7. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM, Chavkin C.
    Mol Pharmacol; 1983 Jan 20; 23(1):36-43. PubMed ID: 6135144
    [No Abstract] [Full Text] [Related]

  • 8. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP, Zhu YX, Lee NM, Loh HH, Way EL.
    J Pharmacol Exp Ther; 1984 Feb 20; 228(2):293-303. PubMed ID: 6141281
    [Abstract] [Full Text] [Related]

  • 9. Profile of activity of kappa receptor agonists in the rabbit vas deferens.
    Hayes A, Kelly A.
    Eur J Pharmacol; 1985 Apr 16; 110(3):317-22. PubMed ID: 2988982
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dynorphin interaction at the kappa-opiate site.
    Huidobro-Toro JP, Yoshimura K, Lee NM, Loh HH, Way EL.
    Eur J Pharmacol; 1981 Jun 19; 72(2-3):265-6. PubMed ID: 6113976
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of the action of putative endogenous kappa-agonists, leumorphin and rimorphin in vitro.
    Suda M, Nakao K, Yoshimasa T, Ikeda Y, Sakamoto M, Yanaihara C, Yanaihara N, Numa S, Imura H.
    Life Sci; 1983 Jun 19; 33 Suppl 1():275-8. PubMed ID: 6319876
    [Abstract] [Full Text] [Related]

  • 13. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
    Koike K, Takayanagi I, Hirakura Y, Matsueda R.
    Arch Int Pharmacodyn Ther; 1991 Jun 19; 313():33-46. PubMed ID: 1687773
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the opioid activity of CAM and kappa agonists.
    Furst S, Friedmann T, Kovacs A, Wagner T.
    NIDA Res Monogr; 1986 Jun 19; 75():224-7. PubMed ID: 2828975
    [Abstract] [Full Text] [Related]

  • 15. The choice of opioid receptor subtype in isolated preparations by ohmefentanyl.
    Jin WQ, Chen XJ, Chi ZQ.
    Sci Sin B; 1987 Feb 19; 30(2):176-81. PubMed ID: 3039656
    [Abstract] [Full Text] [Related]

  • 16. Intrinsic activity and effects of guanyl-5'-yl imidodiphosphate, Gpp(NH)p and sodium ion on the affinity of dynorphin 1-13, nalorphine and nalorphine-7,8-oxide to kappa-opioid receptor.
    Takayanagi I, Okumura K, Konno F, Koike K, Cho N, Hirobe M.
    Gen Pharmacol; 1985 Feb 19; 16(6):617-9. PubMed ID: 2867951
    [Abstract] [Full Text] [Related]

  • 17. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE, Portoghese PS.
    Eur J Pharmacol; 1984 Sep 03; 104(1-2):101-4. PubMed ID: 6094203
    [Abstract] [Full Text] [Related]

  • 18. Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum.
    Yoshimura K, Huidobro-Toro JP, Way EL.
    Eur J Pharmacol; 1982 Oct 15; 84(1-2):17-24. PubMed ID: 6128236
    [Abstract] [Full Text] [Related]

  • 19. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
    Hayes AG, Sheehan MJ, Tyers MB.
    Br J Pharmacol; 1985 Dec 15; 86(4):899-904. PubMed ID: 3000501
    [Abstract] [Full Text] [Related]

  • 20. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S, Schmitt H.
    Eur J Pharmacol; 1983 Dec 09; 96(1-2):165-9. PubMed ID: 6319158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.